INDIVUTEST
DEAD

Serial Number

98206800

Owner

IndivuTest GmbH

Attorney

R. Glenn Schroeder

Filing Date

Oct 2, 2023

Add to watchlist:

No watchlists yet
View on USPTO

INDIVUTEST Trademark

Serial Number: 98206800

INDIVUTEST is a trademark filed by IndivuTest GmbH on October 2, 2023. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

IndivuTest GmbH (3 trademarks)

Falkenried 88
Hamburg 20251 , DE

Entity Type: 11

Trademark Details

Filing Date

October 2, 2023

Registration Date

Not Registered

Published for Opposition

May 20, 2025

Goods & Services

Scientific research; design and development of new technology for others in the field of cancer, metabolic diseases, cardiovascular diseases, inflammatory diseases, diseases of the immune system; analysis of industrial fluids and industrial research in the field of oncology; design and development of computer hardware and software, in particular computer programs; scientific research for medical purposes, in particular molecular biological, immunological and histological laboratory services, in particular scientific research and development in the field of human medical and veterinary medical diagnostics and therapy; scientific research for medical purposes in the field of genetic engineering; research and development services in the field of oncology diagnostics; diagnostic services using standard laboratory equipment for scientific cancer research services purposes; providing diagnostic services for others for scientific research services purposes related to the generation of complex data and data sets obtained by multi-omics analysis of human and animal samples, namely, tissue samples, tissue preparations, tissue cuts, blood plasma, blood serum, ascites, cerebrospinal fluid, human urine and human stool, and provision of such data and data sets in whole or in part, unprocessed or processed, to patients, scientists, physicians, medical institutions or scientific institutions, all in the field of oncology for supporting diagnosis and treatment efforts; generation of complex data and data sets by multi-omics analysis of human and animal sample material, namely, tissue samples, tissue preparations, tissue cuts, blood plasma, blood serum, ascites, cerebrospinal fluid, human urine and human stool, all being biologic analysis scientific research services for the support of oncology diagnosis and treatment; diagnostic services related to generated and/or analysed complex data and data sets received through multi-omics analysis of human and animal sample material, namely, tissue samples, tissue preparations, tissue cuts, blood plasma, blood serum, ascites, cerebrospinal fluid, human urine and human stool, all being scientific research provided for the support of oncology diagnosis and treatment

Diagnostic preparations, in particular made by using molecular biological, molecular genetic, genetic engineering, immunological and biotechnical methods for clinical and laboratory use in the nature of Diagnostic preparations, other than for medical or veterinary purposes

Medical analyses in connection with the treatment of individuals including X-rays and blood samples, namely, medical testing for diagnostic and treatment purposes in the field of cancer; medical clinic services; pharmaceutical advisory services for providing support for pharmaceutical and other treatment advice for oncology patients; medical diagnostic testing, monitoring and reporting services; tissue typing services by means of molecular biological, immunological, and histological methods; generation of complex data and data sets by multi-omics analysis of human and animal sample material, namely, tissue samples, tissue preparations, tissue cuts, blood plasma, blood serum, ascites, cerebrospinal fluid, human and animal urine and human and animal stool, all being body composition analysis services for medical purposes; diagnostic services related to generated and/or analysed complex data and data sets received through multi-omics analysis of human and animal sample material, namely, tissue samples, tissue preparations, tissue cuts, blood plasma, blood serum, ascites, cerebrospinal fluid, human and animal urine and human and animal stool, all being medical diagnostic services

Pharmaceutical and veterinary preparations, in particular medicines for human beings and animals, namely, pharmaceutical and veterinary preparations for the treatment of cancer, metabolic diseases, cardiovascular diseases, inflammatory diseases, diseases of the immune system; human and animal sample material, namely, allograft and xenograft tissue preparations, tissue cuts, blood plasma, blood serum, ascites, cerebrospinal fluid, human and animal urine and human and animal stool, all in nature of cell culture medium for medical use; test kits for human and animal sample material, namely, allograft and xenograft tissue preparations, tissue cuts, blood plasma, blood serum, ascites, cerebrospinal fluid, human and animal urine and human and animal stool, all in the nature of diagnostic test kits comprised of medical diagnostic reagents and assays for testing of human sample material, namely, allograft and xenograft tissue preparations in culture medium for medical use for disease detection, namely, cancer and therapeutic decision making in the field of oncology; diagnostic preparations, in particular made by using molecular biological, molecular genetic, genetic engineering, immunological and biotechnical methods for medical use; therapeutic preparations, in particular made by using molecular biological, molecular genetic, genetic engineering, immunological and biotechnical methods in the nature of therapeutic medicated bath preparations

Electronic apparatus and instruments for scientific laboratory research, namely, electronic analyzers and analyzers for the qualitative and quantitative recognition of samples and identification of the sample type; scientific electronic apparatus for the typing of tissue and tissue samples and tissue cuts; apparatus for recording, transmission or reproduction of data; blank magnetic data carriers; data processing equipment; computers

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Feb 16, 2026 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Feb 16, 2026 ABN6
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 15, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 20, 2025 NPUB
PUBLISHED FOR OPPOSITION
May 20, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 14, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 22, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 22, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 22, 2025 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Apr 22, 2025 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Jan 25, 2025 GNFN
FINAL REFUSAL E-MAILED
Jan 25, 2025 GNFR
FINAL REFUSAL WRITTEN
Jan 25, 2025 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 3, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 3, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 3, 2024 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Aug 21, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Aug 21, 2024 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 4, 2024 GNRN
NON-FINAL ACTION E-MAILED
Jun 4, 2024 GNRT
NON-FINAL ACTION WRITTEN
Jun 4, 2024 CNRT
ASSIGNED TO EXAMINER
May 22, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 12, 2023 NWOS
NEW APPLICATION ENTERED
Oct 5, 2023 NWAP